{"version":"1.0","provider_name":"EMBL","provider_url":"https:\/\/www.embl.org\/news","author_name":"Oana Stroe","author_url":"https:\/\/www.embl.org\/news\/author\/oana-stroe-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-3\/","title":"Patient-derived computational models of cancer in BioModels","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"fwGoJda0Bd\"><a href=\"https:\/\/www.embl.org\/news\/science\/patient-derived-cancer-models-in-biomodels\/\">Computational models of cancer available<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.embl.org\/news\/science\/patient-derived-cancer-models-in-biomodels\/embed\/#?secret=fwGoJda0Bd\" width=\"600\" height=\"338\" title=\"&#8220;Computational models of cancer available&#8221; &#8212; EMBL\" data-secret=\"fwGoJda0Bd\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","description":"\u201cThese models can be interesting tools for researchers developing drugs to treat cancer because each model contains information about the metabolic pathways occurring in individual patients, the age and gender of the patient, as well as the type of cancer,\u201d explains Varun Kothamachu, Postdoctoral Computational Biologist at the Babraham Institute and a Visiting Researcher at EMBL-EBI. https:\/\/news.embl.de\/science\/patient-derived-cancer-models-in-biomodels","thumbnail_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/08\/BioModels_news_EMBL_620x425.jpg","thumbnail_width":778,"thumbnail_height":534}